82 results on '"Sanson, Marc"'
Search Results
2. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
3. Late-onset vascular complications of radiotherapy for primary brain tumors: a case–control and cross-sectional analysis
4. Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy
5. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
6. Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
7. Non-invasive molecular diagnosis in gliomas with advanced imaging
8. PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth
9. Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors
10. Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomas
11. Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort
12. Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
13. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
14. Mechanisms and therapeutic implications of hypermutation in gliomas
15. Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours
16. EGFR gene amplification in monocentric and multicentric glioblastoma
17. Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas
18. Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma
19. Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma
20. A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas
21. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
22. Pazopanib efficacy in recurrent central nervous system hemangiopericytomas
23. Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
24. Impact of atopy on risk of glioma: a Mendelian randomisation study
25. Influence of obesity-related risk factors in the aetiology of glioma
26. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma
27. Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
28. Mendelian randomisation study of the relationship between vitamin D and risk of glioma
29. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas
30. Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy
31. Characteristics of gliomas in patients with somatic IDH mosaicism
32. Quantifying the heritability of glioma using genome-wide complex trait analysis
33. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas
34. Genome-wide association study identifies multiple susceptibility loci for glioma
35. Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
36. Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression
37. Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas
38. VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab
39. Successful treatment of multiple intracranial meningiomas with the antiprogesterone receptor agent mifepristone (RU486)
40. Erratum to: TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas
41. MGMT testing—the challenges for biomarker-based glioma treatment
42. A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma
43. TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas
44. Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
45. Gliomatosis Cerebri: A Review
46. Molecular analysis of diffuse intrinsic brainstem gliomas in adults
47. Novel molecular targets in treatment of glioblastoma
48. Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases
49. Interlaboratory comparison of IDH mutation detection
50. Genome-wide association study of glioma and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.